Wednesday, October 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Blockchain

XRP Trapped at $1.15 as Ripple’s EU License and Exchange Exodus Battle Technical Gravity

Rodolfo Hanigan by Rodolfo Hanigan
July 7, 2026
in Blockchain, Crypto Stocks, Ethereum & Altcoins, European Markets
0
XRP Stock
0
SHARES
41
VIEWS
Share on FacebookShare on Twitter

Ripple has just cleared one of its most significant regulatory hurdles in Europe, yet the XRP token remains pinned below a stubborn resistance zone. The paradox is sharp: corporate progress is accelerating while the market price refuses to follow.

On 6 July 2026, Ripple obtained a full CASP (Crypto Asset Service Provider) licence from Luxembourg’s CSSF, the country’s financial regulator. The approval, granted under the EU’s MiCA framework, arrived days after the 1 July transition deadline and complements Ripple’s existing e-money licence. The combined status allows the company to offer regulated crypto services across all 30 countries of the European Economic Area via passporting, eliminating the need for separate applications in each jurisdiction. Ripple now holds more than 75 regulatory licences globally, and its payment infrastructure has processed over $100 billion in volume across 60 markets. Investors should note, however, that the MiCA licence covers institutional payment and custody services, not the XRP token itself; future demand for the token in Europe depends on how much payment traffic actually routes through the XRP Ledger.

While Ripple cements its institutional footprint, the supply dynamics of XRP are shifting beneath the surface. The XRP scarcity index on Binance climbed to 0.77 on 6 July, its highest level since mid-2024. The metric measures how much XRP is immediately available for sale on the world’s largest exchange — a high reading signals that fewer tokens are sitting on the order book, potentially reducing selling pressure. This trend is mirrored by a dramatic withdrawal of coins from trading platforms overall. Exchange outflows have tripled recently to roughly 123 million tokens, and active addresses on the XRP Ledger have surged 72% in just two weeks. On-chain valuation metrics add to the cautiously bullish picture: the 30-day MVRV ratio sits at minus 45% and the 365-day figure at minus 47%. Historically, such deeply negative readings mark an “opportunity zone” in which most holders are underwater — a constellation that has often preceded recovery phases.

Despite these supply-side tailwinds, XRP’s price remains trapped. The token is changing hands at $1.13, having failed to sustain a breakout above $1.15. On a daily basis it is down 2.36%, though the weekly chart still shows a gain of 6.86%. The secondary article notes that the $1.10 level, which had capped all upside since May, was finally breached — but that breakout has stalled at the next band of resistance between $1.14 and $1.15. The broader trend is still bearish: XRP has lost roughly 39% since the start of the year and trades 69% below its 52-week high of $3.65 set in July 2025. It marked a new yearly low of $1.01 only in late June. The 50-day moving average at $1.19 and the 200-day average at $1.47 both sit above the current price, confirming that the overarching downtrend remains intact. The relative strength index at 50 indicates neutral momentum, neither overbought nor oversold.

Should investors sell immediately? Or is it worth buying XRP?

Institutional capital continues to flow in, providing a floor beneath the market. US spot ETFs on XRP have now logged nine consecutive weeks of net inflows, with last week’s tally reaching $17.19 million. Cumulative inflows across these funds stand at roughly $1.47 billion. This steady accumulation has helped XRP hold above the $1.11 support level amid broader crypto volatility. Yet the bullish impact is capped by the technical ceiling above.

Two key technical zones will determine the next move. The primary support sits at $1.1110; a break below that could trigger a retest of the psychologically important $1.00 mark. On the upside, clearing the $1.14–$1.15 resistance band would open the path toward $1.18–$1.20, with the secondary target at $1.25 if buying pressure persists. Conversely, a drop beneath $1.00 would likely accelerate losses to $0.93.

Beyond the charts, Ripple is also strengthening its market position through strategic initiatives. Portfolio company Evernorth has filed a new trademark on the Cayman Islands as part of an XRP treasury project, and Ripple has joined a Wall Street-backed stablecoin consortium. These moves, combined with the EU licence and the tightening spot supply, create a foundation for a potential reversal — if the price can finally break free of the $1.15 cap.

Ad

XRP Stock: Buy or Sell?! New XRP Analysis from October 6 delivers the answer:

The latest XRP figures speak for themselves: Urgent action needed for XRP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 6.

XRP: Buy or sell? Read more here...

Tags: XRP
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Siemens Energy Stock
Energy & Oil

Siemens Energy: Nuclear Ambitions Meet Chart Warnings as CEO Urges Crisis Preparedness

September 7, 2026
TKMS Stock
Defense & Aerospace

TKMS Closes the Dolphin Chapter and Courts Fincantieri — But Shareholders Are Still Waiting for the Tide to Turn

September 7, 2026
Hensoldt Stock
Defense & Aerospace

Hensoldt’s €10 Billion Backlog Meets a 32% Drawdown: The Bull-Bear Fault Line Widening in Taufkirchen

September 7, 2026
Next Post
Allianz Stock

Allianz Spends €1.5 Billion on Own Shares in Just Over Three Months – And Shows No Signs of Letting Up

Volkswagen Stock

Volkswagen Shares Find a Floor as Analysts See Value, but 100,000 Job Cuts Cast a Long Shadow

FALLBACK Stock

As German Offices Swelter, Sun Protection Measures Spark a New Workplace Vision Crisis

Recommended

Amicus Therapeutics Stock

Amicus Therapeutics: A Biotech Stock Facing Divergent Views

1 year ago
MicroStrategy Stock

Insider Selling Sparks Concern at Strategy Holdings

12 months ago
ReconAfrica Stock

ReconAfrica Advances with Crucial Field Testing in Namibia

6 months ago
Shutterstock Stock

Shutterstock Stock Presents a Compelling Value Proposition

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Nike Sinks to a 13-Year Low While Tesla and Amazon Find Buyers

From GPUs to Guardrails: Q4’s Security Rotation Begins

The Rate Plateau’s Real Winners Aren’t Chipmakers

The K-Shaped Economy Meets a 19-Year High in Yields

Consumer Strength Meets Bond Market Stress Ahead of Q4

Borrowed Bull: Record Margin Debt Meets a Record Foreign Inflow

Trending

PepsiCo Stock
Newsletter

PepsiCo and Delta Put the US Consumer to the Test as Stocks Hit Records

by Stephanie Dugan
October 6, 2026
0

Dear readers, Wall Street is at record levels, and the stocks that depend on household spending are...

Oracle Stock

Cash Flow Beats Backlog as Banks Brace for Earnings

October 5, 2026
AMD Stock

Q4 Stock Picking: Where Scarcity Is Priced In, and Where It Isn’t

October 3, 2026
Nike Stock

Nike Sinks to a 13-Year Low While Tesla and Amazon Find Buyers

October 2, 2026
Alphabet Stock

From GPUs to Guardrails: Q4’s Security Rotation Begins

October 1, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • PepsiCo and Delta Put the US Consumer to the Test as Stocks Hit Records
  • Cash Flow Beats Backlog as Banks Brace for Earnings
  • Q4 Stock Picking: Where Scarcity Is Priced In, and Where It Isn’t

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com